Table 4.
Binary logistic regression analysis for characteristics related to SARS-CoV-2 vaccines hesitancy among participants
| 10 | Model 1a | Model 2a | Model 3a | |||||
|---|---|---|---|---|---|---|---|---|
| Variables | p-value | Crude OR [95% CI] | p-value | Adjusted OR [95% CI] | p-value | Adjusted OR [95% CI] | p-value | Adjusted OR [95% CI] |
| Age | 0.003 | 0.067 | 0.056 | |||||
| ≥ 40 years | 1 | 1 | 1 | |||||
| < 40 years | 1.8 [1.2–2.6] | 1.5 [0.97–2.2] | 1.5 [0.98–2.2] | |||||
| Sex | 0.047 | 0.036 | 0.013 | 0.324 | ||||
| Male | - | 1 | 1 | - | 1 | 1 | ||
| Female | 1.5 [1.1–2.2] | 1.6 [1.03–2.5] | 1.7 [1.1–2.7] | 1.2 [0.8–1.9] | ||||
| Location of activity | 0.011 | 0.009 | 0.010 | 0.011 | ||||
| North of Tunisia | - | 1 | 1 | - | 1 | 1 | ||
| Central of Tunisia | 1.4 [0.9–2.1] | 1.3 [0.8–2.0] | 1.3 [0.8–2.0] | 1.3 [0.8–2.0] | ||||
| Southern of Tunisia | 1.9 [1.2–3.2] | 2.3 [1.3–3.9] | 2.3 [1.3–3.9] | 2.2 [1.3–3.7] | ||||
| Having been already infected by the SARS-CoV-2 | < 0.001 | < 0.001 | < 0.001 | |||||
| No | - | 1 | 1 | - | 1 | |||
| Yes | 0.028 [0.004–0.2] | 0.024 [0.003–0.2] | 0.024 [0.003–0.2] | |||||
| Use of the national site for information about COVID-19: covid.tn | 0.005 | 0.015 | 0.010 | 0.011 | ||||
| No | - | 1 | 1 | - | 1 | 1 | ||
| Yes | 0.6 [0.4–0.8] | 0.6 [0.4–0.9] | 0.6 [0.4–0.9] | 0.6 [0.4–0.9] | ||||
| Think that the vaccines that will be available in Tunisia may contain harmful components | 0.004 | 0.007 | 0.006 | 0.007 | ||||
| No | - | 1 | 1 | - | 1 | 1 | ||
| Yes | 1.8 (1.2–2.6] | 1.8 [1.2–2.7] | 1.8 [1.2–2.7] | 1.7 [1.2–2.6] | ||||
| Sector of activity | 0.025 | 0.025 | ||||||
| Private | 1 | 1 | ||||||
| Public | 1.5 [1.1–2.3] | 1.6 [1.1–2.5] | ||||||
| Frequency of direct contact with COVID-19 inpatients | 0.141 | 0.035 | ||||||
| Every day | 1 | 1 | ||||||
| Sometimes | 1.0 [0.6–1.7] | 1.1 [0.6–1.9] | ||||||
| Never | 1.4 [0.9–2.4] | 1.8 [1.03–3.2] | ||||||
aThe following co-variables were introduced to the initial model: age, gender, location of activity, sector of activity, Frequency of direct contact with COVID-19 inpatients, History of allergy, History of infection by the SARS-CoV-2, use of Social media, use of Television channels, use of The national web site of the Ministry of Health, use of the web site of the Pasteur institute of Tunis, use of the Tunisian web site for health professionals “SAUVE.tn”, use of the Tunisian web site for information about COVID-19, use of newspapers, perception of a lack of information about the SARS-CoV2vaccines, concerns about the components of the upcoming vaccines, perception of a high or very high risk of complications in case of infection by SARS-CoV2